These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1384 related items for PubMed ID: 19217513
21. Effect of ezetimibe on low-density lipoprotein subtype distribution: results of a placebo-controlled, double-blind trial in patients treated by regular low-density lipoprotein apheresis and statins. Geiss HC, Otto C, Parhofer KG. Metabolism; 2006 May; 55(5):599-604. PubMed ID: 16631435 [Abstract] [Full Text] [Related]
22. [Influence of combined, hypolipemic therapy on lipids and non-lipid atherosclerosis risk factors]. Broncel M, Balcerak M, Chojnowska-Jezierska J. Pol Merkur Lekarski; 2007 Jan; 22(127):62-5. PubMed ID: 17477094 [Abstract] [Full Text] [Related]
26. Choosing drug therapy for patients with hyperlipidemia. Safeer RS, Lacivita CL. Am Fam Physician; 2000 Jun 01; 61(11):3371-82. PubMed ID: 10865931 [Abstract] [Full Text] [Related]
27. Safety and effectiveness of ezetimibe in liver transplant recipients with hypercholesterolemia. Almutairi F, Peterson TC, Molinari M, Walsh MJ, Alwayn I, Peltekian KM. Liver Transpl; 2009 May 01; 15(5):504-8. PubMed ID: 19399742 [Abstract] [Full Text] [Related]
30. Effects of ezetimibe add-on to statin therapy on adipokine production in patients with metabolic syndrome and stable vascular disease. Gupta M, Szmitko PE, Tsigoulis M, Braga MF, Kajil M, Herjikaka S, Quan A, Teoh H, Verma S. J Cardiovasc Pharmacol; 2010 Sep 01; 56(3):241-5. PubMed ID: 20505518 [Abstract] [Full Text] [Related]
31. Initial low-density lipoprotein response to statin therapy predicts subsequent low-density lipoprotein response to the addition of ezetimibe. Ziajka PE, Reis M, Kreul S, King H. Am J Cardiol; 2004 Mar 15; 93(6):779-80. PubMed ID: 15019893 [Abstract] [Full Text] [Related]
33. An investigative look: selective cholesterol absorption inhibitors--embarking on a new standard of care. Stein EA. Am J Manag Care; 2002 Feb 15; 8(2 Suppl):S36-9; discussion S45-7. PubMed ID: 11855701 [Abstract] [Full Text] [Related]
34. Achieving cholesterol goals. Current and future drug therapies. Jones PH. Postgrad Med; 2003 Aug 15; 114(2 Suppl):14-21. PubMed ID: 19667635 [Abstract] [Full Text] [Related]
36. A novel therapeutic approach to dyslipidemia. Clearfield MB. J Am Osteopath Assoc; 2003 Jan 15; 103(1 Suppl 1):S16-20. PubMed ID: 12572626 [Abstract] [Full Text] [Related]
37. Efficacy and tolerability of fluvastatin XL 80 mg alone, ezetimibe alone, and the combination of fluvastatin XL 80 mg with ezetimibe in patients with a history of muscle-related side effects with other statins. Stein EA, Ballantyne CM, Windler E, Sirnes PA, Sussekov A, Yigit Z, Seper C, Gimpelewicz CR. Am J Cardiol; 2008 Feb 15; 101(4):490-6. PubMed ID: 18312764 [Abstract] [Full Text] [Related]
38. Effect of ezetimibe coadministration with simvastatin in a Middle Eastern population: a prospective, multicentre, randomized, double-blind, placebo-controlled trial. Zubaid M, Shakir DK, Bazargani N, Binbrek A, Gopal R, Al-Tamimi O, Bakir S. J Cardiovasc Med (Hagerstown); 2008 Jul 15; 9(7):688-93. PubMed ID: 18545068 [Abstract] [Full Text] [Related]
39. Efficacy and safety of combination of extended release niacin and atorvastatin in patients with low levels of high density lipoprotein cholesterol. Harikrishnan S, Rajeev E, Tharakan JA, Titus T, Ajit Kumar VK, Sivasankaran S, Krishnamoorthy KM, Nair K. Indian Heart J; 2008 Jul 15; 60(3):215-22. PubMed ID: 19240310 [Abstract] [Full Text] [Related]
40. Colesevelam hydrochloride: usefulness of a specifically engineered bile acid sequestrant for lowering LDL-cholesterol. Corsini A, Windler E, Farnier M. Eur J Cardiovasc Prev Rehabil; 2009 Feb 15; 16(1):1-9. PubMed ID: 19237992 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]